89 related articles for article (PubMed ID: 22174163)
1. Immunohistochemical expression of vascular endothelial growth factor and its correlation with tumor grade in breast ductal carcinoma.
Ghasemi M; Emadian O; Naghshvar F; Bekhradnia A; Abediankenari S; Vahedi Larijani L; Moghimpour R
Acta Med Iran; 2011; 49(12):776-9. PubMed ID: 22174163
[TBL] [Abstract][Full Text] [Related]
2. Invasive lobular and invasive ductal carcinoma of the breast show distinct patterns of vascular endothelial growth factor expression and angiogenesis.
Lee AH; Dublin EA; Bobrow LG; Poulsom R
J Pathol; 1998 Aug; 185(4):394-401. PubMed ID: 9828838
[TBL] [Abstract][Full Text] [Related]
3. Correlation between vascular endothelial growth factor, angiogenesis, and tumor-associated macrophages in invasive ductal breast carcinoma.
Valković T; Dobrila F; Melato M; Sasso F; Rizzardi C; Jonjić N
Virchows Arch; 2002 Jun; 440(6):583-8. PubMed ID: 12070596
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic correlation of cancer stem cell markers CD44, CD24, VEGF and HIF-1α in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study.
Wang Z; Shi Q; Wang Z; Gu Y; Shen Y; Sun M; Deng M; Zhang H; Fang J; Zhang S; Xie F
Pathol Res Pract; 2011 Aug; 207(8):505-13. PubMed ID: 21802218
[TBL] [Abstract][Full Text] [Related]
5. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.
Brown LF; Guidi AJ; Schnitt SJ; Van De Water L; Iruela-Arispe ML; Yeo TK; Tognazzi K; Dvorak HF
Clin Cancer Res; 1999 May; 5(5):1041-56. PubMed ID: 10353737
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor A (VEGF A) as individual prognostic factor in invasive breast carcinoma.
Cîmpean AM; Raica M; Suciu C; Tătucu D; Sârb S; Mureşan AM
Rom J Morphol Embryol; 2008; 49(3):303-8. PubMed ID: 18758633
[TBL] [Abstract][Full Text] [Related]
7. Over expression of vascular endothelial growth factor in correlation to Ki-67, grade, and stage of breast cancer.
Al-Harris ES; Al-Janabi AA; Al-Toriahi KM; Yasseen AA
Saudi Med J; 2008 Aug; 29(8):1099-104. PubMed ID: 18690299
[TBL] [Abstract][Full Text] [Related]
8. [Expression of angiogenesis-related factors in invasive breast cancer and its clinical significance].
Wang XB; Yang QX; Pei XJ
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):860-3. PubMed ID: 16793622
[TBL] [Abstract][Full Text] [Related]
9. TRAIL death receptor-4 expression positively correlates with the tumor grade in breast cancer patients with invasive ductal carcinoma.
Sanlioglu AD; Korcum AF; Pestereli E; Erdogan G; Karaveli S; Savas B; Griffith TS; Sanlioglu S
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):716-23. PubMed ID: 17512128
[TBL] [Abstract][Full Text] [Related]
10. [Expression of vascular endothelial growth factor and its receptor (Flt-1) in breast carcinoma].
Wu H; Li Y; Zhu G; Zhang L; Zhang X; He X
Zhonghua Yi Xue Za Zhi; 2002 May; 82(10):708-11. PubMed ID: 12133473
[TBL] [Abstract][Full Text] [Related]
11. [Expression of vascular endothelial growth factor A and C in human breast cancer and their significance].
Hu SE; Zhang YJ; Cui YM; Zhang HQ
Ai Zheng; 2005 Sep; 24(9):1076-9. PubMed ID: 16159428
[TBL] [Abstract][Full Text] [Related]
12. Microvessel density, VEGF expression, and tumor-associated macrophages in breast tumors: correlations with prognostic parameters.
Bolat F; Kayaselcuk F; Nursal TZ; Yagmurdur MC; Bal N; Demirhan B
J Exp Clin Cancer Res; 2006 Sep; 25(3):365-72. PubMed ID: 17167977
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor expression in the basal subtype of breast carcinoma.
Ribeiro-Silva A; Ribeiro do Vale F; Zucoloto S
Am J Clin Pathol; 2006 Apr; 125(4):512-8. PubMed ID: 16627261
[TBL] [Abstract][Full Text] [Related]
14. The short form of the alternatively spliced flt-4 but not its ligand vascular endothelial growth factor C is related to lymph node metastasis in human breast cancers.
Gunningham SP; Currie MJ; Han C; Robinson BA; Scott PA; Harris AL; Fox SB
Clin Cancer Res; 2000 Nov; 6(11):4278-86. PubMed ID: 11106244
[TBL] [Abstract][Full Text] [Related]
15. Predicting the biologic behavior of ductal carcinoma in situ: an analysis of molecular markers.
Hieken TJ; Farolan M; D'Alessandro S; Velasco JM
Surgery; 2001 Oct; 130(4):593-600; discussion 600-1. PubMed ID: 11602889
[TBL] [Abstract][Full Text] [Related]
16. Role of COX-2, VEGF and cyclin D1 in mammary infiltrating duct carcinoma.
Lim SC
Oncol Rep; 2003; 10(5):1241-9. PubMed ID: 12883688
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor mRNA levels quantified by reverse transcription-polymerase chain reaction in microdissected breast carcinoma tissues are correlated with histological type and grade of both invasive and intraductal components.
Yamasaki T; Tsuda H; Imazeki N; Matsubara O
Pathol Int; 2005 May; 55(5):255-63. PubMed ID: 15871723
[TBL] [Abstract][Full Text] [Related]
18. Angiogenesis and VEGF expression in pre-invasive lesions of the human breast.
Viacava P; Naccarato AG; Bocci G; Fanelli G; Aretini P; Lonobile A; Evangelista G; Montruccoli G; Bevilacqua G
J Pathol; 2004 Oct; 204(2):140-6. PubMed ID: 15376259
[TBL] [Abstract][Full Text] [Related]
19. Assessment of maturation status of tumor-infiltrating dendritic cells in invasive ductal carcinoma of the breast: relation with vascular endothelial growth factor expression.
El Deeb NM; Mehanna RA
Turk Patoloji Derg; 2013; 29(3):193-200. PubMed ID: 24022309
[TBL] [Abstract][Full Text] [Related]
20. Serum vascular endothelial growth factor in breast cancer: its relation with cancer type and estrogen receptor status.
Heer K; Kumar H; Read JR; Fox JN; Monson JR; Kerin MJ
Clin Cancer Res; 2001 Nov; 7(11):3491-4. PubMed ID: 11705867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]